Clinical trialNACompleted

Proton Radiation for Resectable Carcinoma of the Pancreas

A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas

NCT00763516 ↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome: Finished, no results posted
Phase: NA
Status: Completed
Study type: Interventional
Start: February 2009
Expected end: 17 August 2017
Enrollment: 8 participants
Sites: 1
Primary outcomes: Cumulative incidence of grade 3+ bowel perforation, grade 3+ bleeding and grade 4+ nonhematologic acute adverse events (occuring within 90 days of treatment start)
Sponsor: Other
Results posted: No
Last update: 6 September 2017

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Ask this document

Papers 2